These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 3126101)
1. Treatment for the myelodysplastic syndromes. Jacobs A Haematologica; 1987; 72(6):477-80. PubMed ID: 3126101 [No Abstract] [Full Text] [Related]
2. [Myelodysplastic syndromes]. Guisasola Zulueta MC; Gilsanz Fernández C; Tintó del Val JA; García de la Fuente A Rev Clin Esp; 1986 Sep; 179(4):190-5. PubMed ID: 3764008 [No Abstract] [Full Text] [Related]
3. Differentiation-inducing agents in the treatment of myelodysplastic syndromes. Kizaki M; Koeffler HP Semin Oncol; 1992 Feb; 19(1):95-105. PubMed ID: 1371019 [No Abstract] [Full Text] [Related]
4. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes. Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864 [No Abstract] [Full Text] [Related]
5. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes]. García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051 [TBL] [Abstract][Full Text] [Related]